•  
  •  
 

Authors

Kawther Ben Abdelghani, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Saoussen Miladi, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Yasmine Makhlouf, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Alia Fazaa, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Mariem Sallemi, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Leila Souebni, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Kmar Ouenniche, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Selma Kassab, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Selma Chekili, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Kamel Ben Salem, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Leith Zakraoui, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia
Ahmed Laatar, Department of Rheumatology, Mongi Slim Hospital, La Marsa, Tunisia
University of Tunis El Manar, Tunis, Tunisia, University of Tunis El Manar, Tunis, Tunisia

Abstract

Objectives: Remission is the ultimate purpose of treatment in rheumatoid arthritis (RA). However, even when the most stringent composite scores are used, structural damages can occur; hence, ultrasonography (US) appears to be the best way to assess real remission. This study aimed to investigate the validity of different RA remission scores using US as a reference. Methods: An analytic diagnostic study, of 30 RA patients in remission (according to the Disease Activity Score in 28 Joints [DAS28]) and a control group with active RA, was conducted between January and October 2018 at Mongi Slim Hospital in Tunis, Tunisia. Among them, patients in remission were identified according to their Simple Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI) and the Boolean American College of Rheumatology/European League against Rheumatism activity index (ACR/EULAR) remission scores. The validity of each activity score for remission was calculated by considering the absence of power Doppler (PD) signals as a gold standard. Results: All patients were in remission according to the DAS28, with an average score of 2.03 (1.1–2.6). US examination showed PD signals in 57% of patients. A total of 26 patients were in remission according to the CDAI; a Doppler signal was detected in 58% of those cases. SDAI remission was accomplished in 19 patients, with PD activity in 53% of cases. Of the 14 patients in remission according to the Boolean ACR/EULAR criteria, synovial hyper-vascularisation was found in 64%. Considering true remission as the absence of PD signals, the most sensitive and specific score was the DAS28 (93% and 68%, respectively). Conclusion: Considering remission in RA as the absence of vascularised synovitis, the DAS28 is the most sensitive and most specific score.

Publication Date

7-11-2022

First Page

554

Last Page

560

Creative Commons License

Creative Commons Attribution-No Derivative Works 4.0 International License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International License.

Share

COinS